IFN-γ is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-γ receptors are present in most immune cells, which respond to IFN-γ signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-γ signaling in antigen-presenting cells, and antigen-recognizing B and T lymphocytes, regulates the antigen-specific phases of the immune response. Additionally, IFN-γ stimulates a number of lymphoid cell functions, including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-γ is species-specific and is biologically active only in human and primate cells. Recombinant Human IFN-γ is a 16.8 kDa protein containing 144 amino acid residues.
MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR KRSQMLFQGR RASQ
供应 重组人干扰素 细胞因子 促销450-01Recombinant Human beta-NGFPeprotech
450-34Recombinant Murine β-NGFPeprotech
120-02Recombinant Human BMP-2Peprotech
315-09Recombinant Murine EGFPeprotech
100-15Recombinant Human EGFPeprotech
100-17ARecombinant Human FGF-acidicPeprotech
100-17ARecombinant Human FGF-acidicPeprotech
450-33ARecombinant Murine FGF-acidicPeprotech
100-18BRecombinant Human FGF-basicPeprotech
100-18BRecombinant Human FGF-basicPeprotech
450-33Recombinant Murine FGF-basicPeprotech
250-05Recombinant Murine G-CSFPeprotech
300-23Recombinant Human G-CSFPeprotech
300-03Recombinant Human GM-CSFPeprotech
300-03Recombinant Human GM-CSFPeprotech
315-03Recombinant Murine GM-CSFPeprotech
315-03Recombinant Murine GM-CSFPeprotech
100-39Recombinant Human HGFPeprotech
300-02Recombinant Human IFN-rPeprotech
315-05Recombinant Murine IFN-rPeprotech
100-11Recombinant Human IGF-1Peprotech
100-11Recombinant Human IGF-1Peprotech
250-19Recombinant Murine IGF-1Peprotech
100-19Recombinant Human KGFPeprotech
100-19Recombinant Human KGF(FGF-7)Peprotech
200-01ARecombinant Human IL-1αPeprotech
211-11ARecombinant Murine IL-1aPeprotech
200-01BRecombinant Human IL-1βPeprotech
211-11BRecombinant Murine IL-1βPeprotech
200-02Recombinant Human IL-2Peprotech
200-02Recombinant Human IL-2Peprotech
212-12Recombinant Murine IL-2Peprotech
200-03Recombinant Human IL-3Peprotech
200-03Recombinant Human IL-3Peprotech
213-13Recombinant Murine IL-3Peprotech
200-04Recombinant Human IL-4Peprotech
200-04Recombinant Human IL-4Peprotech
214-14Recombinant Murine IL-4Peprotech
216-16Recombinant Murine IL-6Peprotech
200-06Recombinant Human IL-6Peprotech
200-10Recombinant Human IL-10Peprotech
210-10Recombinant Murine IL-10Peprotech
200-11Recombinant Human IL-11Peprotech
220-11Recombinant Murine IL-11Peprotech
200-12Recombinant Human IL-12Peprotech
210-12Recombinant Murine IL-12Peprotech
200-13Recombinant Human IL-13Peprotech
210-13Recombinant Murine IL-13Peprotech
200-15Recombinant Human IL-15Peprotech
210-15Recombinant Murine IL-15Peprotech
200-17Recombinant Human IL-17Peprotech
210-17Recombinant Murine IL-17Peprotech
300-01ARecombinant Human TNF-aPeprotech
315-01aRecombinant Murine TNF-aPeprotech
100-20Recombinant Human VEGF165Peprotech
100-20Recombinant Human VEGF165Peprotech
450-32Recombinant Murine VEGFPeprotech
CYT-201Recombinant Human EPOProspec
Recombinant Human HGHProspec
CYT-204Recombinant Human IFN-α2aProspec
CYT-205Recombinant Human IFN-α2bProspec